InDevR’s Virus Counter to Streamline Vaccine Development

Boulder, Colorado – January 19, 2010 – InDevR, developer of advanced life science products, today announced the availability of the Virus Counter for rapid virus quantification. The Virus Counter is a unique bio-analytical tool that enables scientists to measure virus particle concentration within minutes. Unlike conventional plaque titer assays, which take days to complete, the Virus Counter provides accurate virus quantification in less than 10 minutes. The unprecedented efficiency and accuracy of virus quantification with the Virus Counter is anticipated to dramatically accelerate vaccine and antiviral therapeutic research and development.

Protein Sciences Corporation in Meriden, Conn. is using the instrument to quantify baculoviruses in a fraction of the time required by traditional methods. “The Virus Counter provides real-time insight into virus production during cell culture fermentation, allowing for immediate use of virus stocks for protein expression,” said Dr. Wafaa Mahmound, Cell Culture Manager.

MedImmune, the world leader in attenuated live virus vaccines, is also making use of the Virus Counter. According to Dr. Kuldip Sra, Principal Scientist of Vaccine Analytical Sciences, “Over the past four years, we have worked closely with InDevR scientists, providing evaluation and feedback during development of the Virus Counter. The technology is now mature and we look forward to employing the Virus Counter to streamline several processes in vaccine development.”

The Virus Counter represents the next generation of compact “personal” flow cytometers designed for a specific application. The Virus Counter works for both RNA and DNA viruses and researchers will find that the instrument assay is fast, cost-effective, and easy to use. For purified viruses, the assay involves a simple staining step followed by a 5- to 10-minute analysis on the Virus Counter. Virus Counter InCyt software is intuitive and features real-time data analysis that further reduces the time-to-results.

“The Virus Counter is the first in a series of affordable, easy-to-use tools we are developing to deliver critical results in dramatically less time than traditional microbiological methods,” said Dr. Kathy Rowlen, InDevR co-founder and CEO. “InDevR’s goal is to empower scientists with new tools, such as the Virus Counter, that can significantly enhance productivity.”

The Virus Counter is available directly from InDevR. Each instrument comes complete with a computer, InCyt software, and a starter kit containing all of the necessary supplies to get up and running. InDevR also offers supply reordering on its website for one-stop shopping.

About InDevR

InDevR is a privately held company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms. InDevR intends to revolutionize microbiological analysis with affordable, easy-to-use instrumentation and assays that deliver reliable results in less time than required for traditional methods. InDevR’s products provide scientists with new tools to aid in their quest to extend knowledge of viruses. Designed for application in fields ranging from fundamental research in gene therapy to vaccine development and surveillance of pathogens, InDevR’s products streamline microbiological analysis. More information about InDevR’s products and services can be found at www.indevr.com